Exeter Financial’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87M Sell
12,091
-99
-0.8% -$20.6K 1.1% 36
2026
Q1
$2.58M Sell
12,190
-292
-2% -$62.9K 1.05% 37
2025
Q4
$2.57M Sell
12,482
-526
-4% -$99K 1.09% 34
2025
Q3
$2.04M Sell
13,008
-842
-6% -$130K 0.88% 40
2025
Q2
$2.33M Sell
13,850
-781
-5% -$116K 1.04% 37
2025
Q1
$2.02M Sell
14,631
-79
-0.5% -$10.1K 0.9% 42
2024
Q4
$1.74M Sell
14,710
-47
-0.3% -$5.49K 0.8% 44
2024
Q3
$1.63M Buy
14,757
+128
+0.9% +$13.4K 0.72% 47
2024
Q2
$1.44M Buy
14,629
+172
+1% +$17.5K 0.69% 49
2024
Q1
$1.59M Buy
14,457
+349
+2% +$37.7K 0.73% 47
2023
Q4
$1.46M Buy
14,108
+691
+5% +$68.6K 0.71% 50
2023
Q3
$1.16M Buy
13,417
+271
+2% +$24.5K 0.62% 53
2023
Q2
$1.24M Sell
13,146
-5,630
-30% -$476K 0.64% 52
2023
Q1
$1.49M Buy
18,776
+25
+0.1% +$1.89K 0.75% 50
2022
Q4
$1.44M Sell
18,751
-147
-0.8% -$11.2K 0.75% 50
2022
Q3
$1.26M Buy
18,898
+219
+1% +$13.9K 0.73% 51
2022
Q2
$976K Buy
18,679
+277
+2% +$15.7K 0.54% 58
2022
Q1
$1.04M Sell
18,402
-1,773
-9% -$95K 0.57% 57
2021
Q4
$1.03M Buy
20,175
+782
+4% +$38.4K 0.56% 56
2021
Q3
$959K Buy
19,393
+252
+1% +$13.7K 0.57% 56
2021
Q2
$1.11M Buy
19,141
+1,404
+8% +$82K 0.64% 54
2021
Q1
$1.08M Buy
17,737
+926
+6% +$51.1K 0.68% 53
2020
Q4
$900K Buy
16,811
+652
+4% +$33.8K 0.62% 53
2020
Q3
$759K Buy
16,159
+109
+0.7% +$5.59K 0.59% 51
2020
Q2
$838K Buy
16,050
+10
+0.1% +$516 0.7% 50
2020
Q1
$769K Buy
16,040
+275
+2% +$14.3K 0.72% 50
2019
Q4
$797K Sell
15,765
-55
-0.3% -$2.84K 0.62% 52
2019
Q3
$747K Buy
15,820
+236
+2% +$10.8K 0.59% 54
2019
Q2
$734K Buy
15,584
+964
+7% +$44.5K 0.61% 54
2019
Q1
$704K Buy
14,620
+28
+0.2% +$1.4K 0.61% 54
2018
Q4
$651K Buy
14,592
+590
+4% +$30.8K 0.61% 55
2018
Q3
$756K Buy
14,002
+2,407
+21% +$123K 0.62% 57
2018
Q2
$566K Buy
11,595
+852
+8% +$48.3K 0.5% 59
2018
Q1
$673K Buy
+10,743
New +$737K 0.58% 58

Other funds holding CAH

Exeter Financial's CAH Position: Q2 2026 in Review

Exeter Financial reduced its Cardinal Health (CAH) stake by 0.81% in Q2 2026, selling an estimated $20.6K and leaving 12,091 shares worth $2.87M. The position accounts for 1.1% of the portfolio, ranked #36.

Exeter Financial first reported a position in CAH in Q1 2018 and has held it in 34 quarters since. 512 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Exeter Financial held 12,091 shares of Cardinal Health worth $2.87M as of Q2 2026.
  • Exeter Financial sold 99 Cardinal Health shares in Q2 2026, an estimated $20.6K.
  • Cardinal Health made up 1.1% of Exeter Financial's portfolio in Q2 2026, its #36 holding.
  • Exeter Financial first reported a position in Cardinal Health in Q1 2018 and has held it in 34 quarters since.
  • 512 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Exeter Financial's 13F filing for Q2 2026, filed 16 Jul 2026.